Association of abnormal lipid spectrum with the disease activity of Takayasu arteritis

被引:19
作者
Wang, X. [1 ,2 ]
Chen, B. [1 ,2 ]
Lv, N. [1 ,2 ]
Liu, Q. [1 ,2 ]
Dang, Aimin [1 ,2 ]
机构
[1] Chinese Acad Med Sci, Fuwai Hosp, Natl Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis, Beijing 100037, Peoples R China
[2] Peking Union Med Coll, Beijing 100037, Peoples R China
基金
高等学校博士学科点专项科研基金; 中国国家自然科学基金;
关键词
ApoB/ApoA1; ratio; Atherosclerosis; Disease activity; Takayasu arteritis; APOLIPOPROTEIN-B; METABOLIC SYNDROME; CARDIOVASCULAR RISK; A-I; INFLAMMATION; CHOLESTEROL; RATIO; PREDICTOR; STIFFNESS; LIPASE;
D O I
10.1007/s10067-014-2819-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Our study aimed to determine whether proatherogenic lipid profiles exist in patients with active Takayasu arteritis (TA) and assess the relationship between different lipid profiles and disease activity in TA. A total of 132 premenopausal female patients with TA and 100 sex-, age-, and body mass index-matched healthy controls were included in our study. The clinical data were collected in detail from all participants. Patients with active TA had significantly lower levels of apolipoprotein A1 (apoA1) (1.47 +/- 0.30 vs. 1.99 +/- 0.33 mmol/L, p < 0.001) and lower levels of high-density lipoprotein cholesterol (HDL-C) (1.23 +/- 0.33 vs. 1.68 +/- 0.38 mmol/L, p < 0.001) than patients with inactive TA. However, they had higher ratios of apolipoprotein B (apoB)/apoA1 (0.74 +/- 0.27 vs. 0.48 +/- 0.14, p < 0.001) compared with patients with inactive TA. Multiple linear regression analysis demonstrated that the apoB/apoA1 ratio was independently associated with TA activity (beta = 0.38, p = 0.04). In addition, multivariate stepwise forward regression analysis showed that the apoB/apoA1 ratio was the major determinant for high-sensitivity C-reactive protein (beta = 0.58, p = 0.002). Our findings indicate that patients with active TA had proatherogenic lipid profiles. In addition, the ratio of apoB to apoA1 could be used as a marker for monitoring and targeting patients with TA.
引用
收藏
页码:1243 / 1248
页数:6
相关论文
共 50 条
[31]   Contrast-enhanced ultrasound for evaluating arteritis activity in Takayasu arteritis patients [J].
Wang, Ying ;
Wang, Ya-Hong ;
Tian, Xin-Ping ;
Wang, Hong-Yan ;
Li, Jing ;
Ge, Zhi-Tong ;
Yang, Yun-Jiao ;
Cai, Sheng ;
Zeng, Xiao-Feng ;
Li, Jian-Chu .
CLINICAL RHEUMATOLOGY, 2020, 39 (04) :1229-1235
[32]   Vascular ultrasound for monitoring of inflammatory activity in Takayasu arteritis [J].
Svensson, Christina ;
Eriksson, Per ;
Zachrisson, Helene .
CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING, 2020, 40 (01) :37-45
[33]   Mycophenolate mofetil reduces disease activity and steroid dosage in Takayasu arteritis [J].
Shinjo, Samuel K. ;
Pereira, Rosa M. R. ;
Tizziani, Vivian A. P. ;
Radu, Ari S. ;
Levy-Neto, Mauricio .
CLINICAL RHEUMATOLOGY, 2007, 26 (11) :1871-1875
[34]   Imaging is the major determinant in the assessment of disease activity in Takayasu's arteritis [J].
Kenar, G. ;
Karaman, S. ;
Cetin, P. ;
Yarkan, H. ;
Akar, S. ;
Can, G. ;
Alastas, O. ;
Gulcu, A. ;
Onen, F. .
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2020, 38 (02) :S55-S60
[35]   Mycophenolate mofetil reduces disease activity and steroid dosage in Takayasu arteritis [J].
Samuel K. Shinjo ;
Rosa M. R. Pereira ;
Vivian A. P. Tizziani ;
Ari S. Radu ;
Maurício Levy-Neto .
Clinical Rheumatology, 2007, 26 :1871-1875
[36]   Ghrelin and adipokines as circulating markers of disease activity in patients with Takayasu arteritis [J].
Hatice Yilmaz ;
Vedat Gerdan ;
Didem Kozaci ;
Dilek Solmaz ;
Servet Akar ;
Gercek Can ;
Aytac Gulcu ;
Yigit Goktay ;
Ismail Sari ;
Merih Birlik ;
Nurullah Akkoc ;
Fatos Onen .
Arthritis Research & Therapy, 14
[37]   Ghrelin and adipokines as circulating markers of disease activity in patients with Takayasu arteritis [J].
Yilmaz, Hatice ;
Gerdan, Vedat ;
Kozaci, Didem ;
Solmaz, Dilek ;
Akar, Servet ;
Can, Gercek ;
Gulcu, Aytac ;
Goktay, Yigit ;
Sari, Ismail ;
Birlik, Merih ;
Akkoc, Nurullah ;
Onen, Fatos .
ARTHRITIS RESEARCH & THERAPY, 2012, 14 (06)
[38]   YKL-40 as a new biomarker of disease activity in Takayasu arteritis [J].
Sun, Ying ;
Kong, Xiufang ;
Wu, Sifan ;
Ma, Lili ;
Yan, Yan ;
Lv, Peng ;
Jiang, Lindi .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2019, 293 :231-237
[39]   Serum amyloid A as a marker of disease activity and treatment response in Takayasu arteritis [J].
Aswin M. Nair ;
Ruchika Goel ;
M. Hindhumati ;
K. Jayakanthan ;
J. Visalakshi ;
George Joseph ;
Sumita Danda ;
Debashish Danda .
Rheumatology International, 2017, 37 :1643-1649
[40]   Outcome Measures and Biomarkers for Disease Assessment in Takayasu Arteritis [J].
Misra, Durga Prasanna ;
Jain, Neeraj ;
Ora, Manish ;
Singh, Kritika ;
Agarwal, Vikas ;
Sharma, Aman .
DIAGNOSTICS, 2022, 12 (10)